Healthpeak Properties (NYSE:DOC) Sets New 52-Week High – Should You Buy?

Healthpeak Properties, Inc. (NYSE:DOC)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $22.81 and last traded at $22.8180, with a volume of 2223794 shares. The stock had previously closed at $22.52.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Citigroup lifted their target price on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Raymond James Financial started coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating on the stock. UBS Group lifted their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, JPMorgan Chase & Co. increased their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus target price of $20.62.

Healthpeak Properties Stock Performance

The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The business’s 50 day moving average is $20.92 and its two-hundred day moving average is $18.59. The company has a market cap of $15.17 billion, a PE ratio of 68.77, a PEG ratio of 3.54 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.5%. Healthpeak Properties’s dividend payout ratio is 381.25%.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of Healthpeak Properties during the fourth quarter valued at approximately $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Healthpeak Properties by 60.3% during the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after acquiring an additional 5,815,189 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Healthpeak Properties by 27.5% in the 1st quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock valued at $195,316,000 after acquiring an additional 2,563,407 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.